EX-229

CAS No. 1219739-36-2

EX-229( EX 229 | EX229 )

Catalog No. M10829 CAS No. 1219739-36-2

A small molecule AMPK activator that dose-dependently increases AMPK activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 73 In Stock
2MG 42 In Stock
5MG 65 In Stock
10MG 107 In Stock
25MG 221 In Stock
50MG 368 In Stock
100MG 553 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    EX-229
  • Note
    Research use only, not for human use.
  • Brief Description
    A small molecule AMPK activator that dose-dependently increases AMPK activity.
  • Description
    A small molecule AMPK activator that dose-dependently increases AMPK activity of α1-, α2-, β1- and β2-containing complexes at 50 uM; induces AMPK activation and glucose uptak in a wortmannin-independent manner; increases fatty acid oxidation in L6 myotubes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    EX 229 | EX229
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    AMPK
  • Recptor
    AMPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1219739-36-2
  • Formula Weight
    431.876
  • Molecular Formula
    C24H18ClN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 5.4 mg/mL12.50 mM
  • SMILES
    O=C(O)C1=CC(OC2=NC3=CC(C4=CC5=C(N(C)C=C5)C=C4)=C(Cl)C=C3N2)=CC=C1C
  • Chemical Name
    5-{[6-chloro-5-(1-methylindol-5-yl)-1H-benzimidazol-2-yl]oxy}-2-methyl-benzoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lai YC, et al. Biochem J. 2014 Jun 15;460(3):363-75. 2. Bultot L, et al. Am J Physiol Endocrinol Metab. 2016 Oct 1;311(4):E706-E719. 3. Patent WO2010036613, EX229.
molnova catalog
related products
  • PF-06409577

    PF-06409577(PF06409577, PF 6409577)?is a potent, selective AMPK β1-containing isoforms activator with TR-FRET EC50 of 7.0 and 6.8 nM for α1β1γ1 and α2β1γ1, respectively.

  • Dorsomorphin

    Dorsomorphin (BML-275, Compound C) is a potent, selective and reversible AMPK inhibitor with Ki of 109 nM.

  • Kahweol

    Kahweol has anticarcinogenic, anti-angiogenic,and anti-inflammatory activities.